()-Epigallocatechin-3-gallate Inhibits EBV Lytic Replication Via Targeting LMP1-Mediated MAPK Signal Axes.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics（2021）
Key words
Latent membrane protein 1 (LMP1),Epstein-Barr virus (EBV) lytic replication,MAPKs,p53,(-)-Epigallocatechin-3-gallate (EGCG)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined